ES2033871T3 - Un procedimiento para producir una preparacion de insulina para administracion parenteral. - Google Patents

Un procedimiento para producir una preparacion de insulina para administracion parenteral.

Info

Publication number
ES2033871T3
ES2033871T3 ES198787309229T ES87309229T ES2033871T3 ES 2033871 T3 ES2033871 T3 ES 2033871T3 ES 198787309229 T ES198787309229 T ES 198787309229T ES 87309229 T ES87309229 T ES 87309229T ES 2033871 T3 ES2033871 T3 ES 2033871T3
Authority
ES
Spain
Prior art keywords
parenteral administration
procedure
producing
insulin preparation
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787309229T
Other languages
English (en)
Spanish (es)
Inventor
Klavs Holger Joergensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2033871T3 publication Critical patent/ES2033871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ES198787309229T 1986-10-20 1987-10-19 Un procedimiento para producir una preparacion de insulina para administracion parenteral. Expired - Lifetime ES2033871T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK356987A DK356987D0 (enExample) 1987-07-10 1987-07-10

Publications (1)

Publication Number Publication Date
ES2033871T3 true ES2033871T3 (es) 1993-04-01

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787309229T Expired - Lifetime ES2033871T3 (es) 1986-10-20 1987-10-19 Un procedimiento para producir una preparacion de insulina para administracion parenteral.

Country Status (18)

Country Link
US (1) US5070186A (enExample)
EP (1) EP0265213B1 (enExample)
KR (1) KR880004819A (enExample)
CN (1) CN87107049A (enExample)
AU (1) AU616381B2 (enExample)
CA (1) CA1316819C (enExample)
DE (1) DE3778287D1 (enExample)
ES (1) ES2033871T3 (enExample)
FI (1) FI86254C (enExample)
GR (1) GR3004912T3 (enExample)
HU (1) HU201475B (enExample)
IE (1) IE60264B1 (enExample)
IL (1) IL84203A (enExample)
NO (1) NO170754C (enExample)
NZ (1) NZ222214A (enExample)
PH (1) PH23446A (enExample)
PT (1) PT85949B (enExample)
YU (1) YU46665B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
DE69924232D1 (de) * 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
IL160044A0 (en) * 2001-08-27 2004-06-20 Novo Nordisk As A cartridge and a medical delivery system accommodating such cartridge
CA2512052C (en) * 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
WO2007076131A2 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
EP2152243A2 (en) * 2007-04-30 2010-02-17 Novo Nordisk A/S Highly concentrated insulin solutions and compositions
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
MX369511B (es) 2013-04-03 2019-11-11 Sanofi Sa Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada.
AU2014333979B2 (en) 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
YU191887A (en) 1989-04-30
CN87107049A (zh) 1988-07-06
IE872799L (en) 1988-04-20
FI874596L (fi) 1988-04-21
NZ222214A (en) 1989-11-28
FI86254B (fi) 1992-04-30
PH23446A (en) 1989-08-07
KR880004819A (ko) 1988-06-27
NO170754B (no) 1992-08-24
YU46665B (sh) 1994-01-20
DE3778287D1 (de) 1992-05-21
NO874347D0 (no) 1987-10-19
HU201475B (en) 1990-11-28
NO170754C (no) 1992-12-02
PT85949A (en) 1987-11-01
PT85949B (pt) 1990-07-31
AU616381B2 (en) 1991-10-31
EP0265213A3 (en) 1988-11-09
EP0265213A2 (en) 1988-04-27
GR3004912T3 (enExample) 1993-04-28
HUT46232A (en) 1988-10-28
EP0265213B1 (en) 1992-04-15
FI874596A0 (fi) 1987-10-19
US5070186A (en) 1991-12-03
IE60264B1 (en) 1994-06-29
FI86254C (fi) 1992-08-10
CA1316819C (en) 1993-04-27
NO874347L (no) 1988-04-21
IL84203A (en) 1993-04-04
AU7990787A (en) 1988-04-21

Similar Documents

Publication Publication Date Title
IE872799L (en) Peptide preparation
DK642587D0 (da) Insulinpraeparat
SE8402560D0 (sv) Farmaceutisk komposition
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
SE8600998L (sv) Parenterala fenytoinpreparat
DE3770830D1 (de) Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
AU2861389A (en) Disubstituted pyridines
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
JPS5244222A (en) Method of making insulin preparations for rectal application
KR840001279A (ko) 항종양 물질의 제조방법
EP0132359A3 (en) Natural human interleukin-2 and production thereof
DE69031569D1 (de) Podophyllotoxinzubereitung enthaltend triglyceride
DK499583D0 (da) Fremgangsmade til fremstilling af en isoquinolinforbindelse
GB1497372A (en) Process for preparation of 8-exo-hydroxy-endotricyclo(5.2.2.02,6)undecane
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ES2059479T3 (es) Procedimiento para preparar pregneno-oxazolinas.
JPS539312A (en) Preparation of light-stable mecobalamin or cobamamide parenteral injections
DK540087A (da) Peptidpraeparat
JPS52148699A (en) Preparation of low salt soy
JPS5435285A (en) Preparation of l-threonine by fermentation
SU1120394A1 (ru) Способ моделировани атрио-вентрикул рного блока сердца
JPS5417182A (en) Preparation of choline-oxidase
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
IT1209617B (it) Procedimento per la preparazione di alchilarileteri.
JPS55157514A (en) Anticancer drug solution comprising eosine yellowish as main constituent

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 265213

Country of ref document: ES